Australian Clinical Labs Limited Price (ACL.AX)

Stock Price

Low: Year Low
High: Year High

Market Cap

Fetching Data...

Enterprise Value

Fetching Data...

Fetching Data...

Shares Outstanding

199,472,019

(0.8173)%

Income Statement Summary

Revenue
Cost of Revenue
Gross Profit
Operating Expenses
Operating Income
Other Expenses
Net Income
news-img
Australian Clinical Labs Limited
news-img

Income Statement

Australian Clinical Labs Limited

Currency: AUD

YEAR 2017 2018 2019 2020 2021 2022 2023 2024
Revenue
Revenue 339.77M

+0%

376.09M

+11%

445.89M

+19%

487.53M

+9%

641.31M

+32%

989.30M

+54%

692.10M

-30%

689.73M

0%

Cost of Revenue
Cost of Revenue 57.68M 265.85M 313.89M 402.49M 119.59M 207.59M 126.08M 442.37M
Gross Profit
Gross Profit 282.09M

+0%

110.24M

-61%

132.00M

+20%

85.04M

-36%

521.73M

+513%

781.71M

+50%

566.02M

-28%

247.36M

-56%

Gross Profit Ratio (0.83%) (0.29%) (0.30%) (0.17%) (0.81%) (0.79%) (0.82%) (0.36%)
Operating Expenses
Research and Development 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
General and Administrative 0.00 0.00 0.00 0.00 249.69M 314.00M 297.39M 312.67M
Selling, General & Admin... 251.50M 116.15M 139.58M 69.51M 249.69M 314.00M 297.39M 87.19M
Selling & Marketing Exp... 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -225,475,000.00
Depreciation and Amortiz... 12.51M 11.32M 11.51M 77.90M 88.05M 106.10M 122.76M 128.43M
Other Expenses 0.00 0.00 0.00 0.00 3.36M -1,073,000.00 10.03M 201.83M
Total Operating Expenses 306.32M 116.15M 139.58M 69.51M 416.54M 514.03M 514.05M 81.55M
Cost and Exponses 364.00M 382.00M 453.47M 472.00M 536.12M 721.62M 640.14M 632.82M
Operating Income
Operating Income -20,569,000.00

+0%

-5,909,000.00

-71%

-7,578,000.00

+28%

15.53M

-305%

97.59M

+528%

256.24M

+163%

51.85M

-80%

56.91M

+10%

Operating Income Ratio (-0.06%) (-0.02%) (-0.02%) (0.03%) (0.15%) (0.26%) (0.07%) (0.08%)
Other Income and Exp...
Interest Income 3.38M 47.00k 38.00k 38.00k 75.00k 45.00k 182.00k 501.00k
Interest Expenses 0.00 3.65M 3.94M 16.57M 10.94M 1.34M 3.54M 17.04M
Total Other Income/Exp... -58,200,000.00 -1,732,000.00 2.38M 1.17M -35,957,000.00 -12,777,000.00 -3,657,000.00 -20,539,000.00
EBITDA
EBITDA -8,058,999.00 5.41M 3.93M 116.30M 196.67M 372.75M 184.93M 169.65M
EBITDA ratio (-0.02%) (0.01%) (0.01%) (0.19%) (0.29%) (0.37%) (0.25%) (0.25%)
Income Before Tax
Income Before Tax -27,612,000.00 -7,641,000.00 -9,704,000.00 30.89M 86.65M 254.90M 48.31M 36.37M
Income Before Tax Ratio (-0.08%) (-0.02%) (-0.02%) (0.06%) (0.14%) (0.26%) (0.07%) (0.05%)
Income Tax Expense
Income Tax Expense 3.58M 1.37M 820.00k -10,425,000.00 26.26M 76.50M 12.27M 12.12M
Net Income
Net Income -24,031,000.00

+0%

-9,012,000.00

-62%

-10,524,000.00

+17%

41.26M

-492%

60.37M

+46%

178.24M

+195%

35.90M

-80%

23.93M

-33%

Net Income Ratio (-0.07%) (-0.02%) (-0.02%) (0.08%) (0.09%) (0.18%) (0.05%) (0.03%)
Earning Per Share
Basic EPS -0.12 -0.04 -0.05 0.20 0.40 0.89 0.18 0.12
Diluted EPS -0.12 -0.04 -0.05 0.20 0.40 0.88 0.18 0.12
Share Outstanding
Basic Share Outstanding 202.30M 202.30M 202.30M 202.30M 152.10M 201.29M 200.57M 198.90M
Diluted Share Outstanding 202.30M 202.30M 202.30M 202.30M 152.10M 201.49M 201.12M 199.47M
8 New Orders
close
Theme Customizer

Customize your theme

close

Theme variation